Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
After 9.1 years of follow-up, a trend toward better long-term imatinib failure-free survival in imatinib treated patients was observed in high-risk subgroup
Approval concerns the treatment of patients with tumours without EGFR, ALK or ROS1 aberrations
Tisagenlecleucel outcomes in relapsed or refractory DLBCL and follicular lymphoma
Long-term follow-up due to risk of cancer
Real-world findings
Cardiac safety is confirmed with longer follow-up after adjuvant dual anti-HER2 treatment for node-positive, HER2-positive early breast cancer
It should be considered as an early surrogate endpoint for clinical trials
They received a positive opinion for the treatment of carcinoma of the colon or rectum, breast cancer, NSCLC, RCC, epithelial ovarian cancer, and carcinoma of the cervix
Evidence for efficacy is based on the results from the Study 1620
During treatment with umbralisib, prophylaxis is recommended for Pneumocystis jirovecii pneumonia and to consider prophylactic antivirals to prevent CMV infection, including CMV reactivation
Two large case–control studies provide important information on the risk of breast cancer and cancer types that is associated with several genes and their variants
The ESMO ESCAT classification can be used to guide in the selection of patients with head and neck squamous cell carcinoma for targeted treatment strategies in clinical studies
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
